BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Hemispherx Biopharma Announces The Completion Of The Newly Upgraded Alferon Facility: Commercial Production Of Alferon Is In The Final Stage Integrating Continuous Flow Manufacturing Technology

  March 2, 2015

   · 

  6 min read
• Business

  Genmab A/S Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG Is Now Effective

  March 2, 2015

   · 

  3 min read
• Policy

  Boehringer Ingelheim Submits Biologics License Application To FDA For Idarucizumab, Investigational Specific Reversal Agent For Pradaxa (Dabigatran Etexilate Mesylate)

  March 2, 2015

   · 

  9 min read
• Policy

  Merus Labs International Inc. Announces Settlement Of Canadian Patent Litigation

  March 2, 2015

   · 

  1 min read
• FDA

  Actavis Receives Approval From The European Commission For XYDALBA (dalbavancin)

  March 2, 2015

   · 

  5 min read
• Business

  Intercept Pharmaceuticals Announces 2014 Financial Results

  March 2, 2015

   · 

  9 min read
• Genetown

  Aegerion Observes Rare Disease Day

  March 2, 2015

   · 

  1 min read
• Pharm Country

  Advaxis, Inc. To Present At The Cowen and Company 35th Annual Health Care Conference

  March 2, 2015

   · 

  4 min read
• Business

  Second Quarter Results - Fiscal 2015 - Ergoresearch Inc. Reports Its Results For The Quarter Ended December 31, 2014

  March 2, 2015

   · 

  5 min read
• Pharm Country

  Agile Therapeutics, Inc. To Present At The 27th Annual ROTH Conferencea

  March 2, 2015

   · 

  1 min read